Some topics can be considered as being highly represented in the JBP, in particular those related to mycobacterial diseases and obstructive airway diseases. That could not be otherwise, given that those are major public health problems and, as such, deserve to be emphasized, as well as because intervention policies targeting such diseases have an impact on a signifi cant number of patients.
Among mycobacterial diseases, tuberculosis undoubtedly garners the most attention. In recent years, the JBP has published dozens of articles providing details on the epidemiology, diagnosis, and treatment of tuberculosis. (1) (2) (3) Likewise, the various aspects of COPD and asthma have been widely debated in our Journal. (4, 5) If the intention of an offi cial organ of dissemination of a scientifi c society is to keep its constituents up to date on the main aspects of the fi eld in question, these data suggest a way forward.
There are numerous highly prevalent conditions that are underrepresented in our Journal. Perhaps the most striking examples are sleep-related breathing disorders and venous thromboembolism. Despite the epidemiological importance of both, the JBP has published an insignifi cant number of articles on those topics in the last decade. That raises the following question: is this low representativeness a refl ection of the current state of research on those topics in our country, or (worse) does it refl ect a progressive loss of interest or reduced participation of the members of our scientifi c society in these areas of activity? If the fi rst hypothesis can be refuted on the basis of articles published in the international literature by highly cited Brazilian researchers, the second should be the subject of refl ection and ongoing efforts by all of the parties involved. There is also a third, intermediate, hypothesis that could explain the low representativeness of those topics in the JBP: it is possible that cutting-edge research on those topics is being conducted but that the scope of that research is still too limited to prompt submission for publication in high-impact journals or in those with a more regional readership.
Despite the fact that it is not possible to provide a direct, objective answer to the question posed above, we have sought to increase the exposure of highly prevalent conditions that were previously underrepresented, in order to provide the reader with a reliable means of remaining up to date, as well as to raise awareness of the research groups existing in Brazil, particularly those working in the areas of interest. Therefore, diagnostic and therapeutic guidelines have both been discussed in depth. (6) (7) (8) In the near future, it might be worthwhile to utilize the JBP as a forum for discussion regarding the true role of the members of our scientifi c society in such areas, as well as to understand the need to create continuing education sections that contemplate those topics. In addition, it is important to analyze publications in these areas over time as a way of determining whether their exposure in recent years has had any signifi cant impact.
In the JBP, not only has there been an increase in the publication of articles related to clinical conditions that are more rare or poorly investigated but such articles have also become some of the most widely cited JBP articles. (9, 10) Nevertheless, the approach chosen was to seek to discuss the rarer situations through review articles. The aim was to make knowledge of poorly explored topics more accessible. Interstitial lung diseases and the evaluation of respiratory muscle function are clear examples of the demand for using the JBP as a resource for continuing education, an approach that could be translated directly to clinical practice. (11, 12) Maintaining a balance between the unequivocal interest in the most prevalent diseases and the need to explore incipient areas, including the exposure of conditions that are more rare, as well as the need to increase the representativeness of our Journal, is not a simple task and was the object of refl ection in another editorial published previously in the JBP. (13) However, it is more than necessary in an environment such as ours, in which there is considerable heterogeneity in terms of the availability of resources and access to knowledge. The fruits of this attempt, initiated four years ago, will be known only in the (not too distant) future (14) . Nevertheless, it was undoubtedly a journey of absolute learning and exchange with the most distinguished researchers in Brazil, a signifi cant number of whom are on the editorial board of our Journal, having been active participants in this journey. All of those researchers have our unequivocal, eternal gratitude. It is also certain that this path is as broad as the interest aroused in the reader-that is perhaps the key to growth: to generate interest in the most robust aspects of the fi eld of pulmonology in Brazil, which has been consistently growing. Everyone involved has worked to see that growth refl ected in our Journal, which now passes into the hands of its new Editor-in-Chief, Bruno Baldi, who has long been a member of its editorial board. I trust that his editorship will be well received and that he will enjoy the collaboration of all parties, in order to continue to expand the dissemination of the best of what is produced in respiratory medicine in Brazil.
